Mirodia Therapeutics
PrivateLast Round
Seed
Nov 1, 2019
Company Overview
Mirodia Therapeutics is a biotechnology company focused on developing topical disease-modifying regenerative medicines for olfactory loss and dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirodia Therapeutics Comparables
Compare Mirodia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Senvera Therapeutics | 93% | |
| Cyrano Therapeutics | 81% | |
| Spiral Therapeutics | 57% |
Mirodia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 1, 2019 |
Mirodia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Remiges Ventures | Seed |
| ANRI株式会社 | Seed |
| Taiho Innovations, LLC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2019
Raised Seed round with ANRI株式会社, Remiges Ventures, and Taiho Innovations.
Mirodia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mirodia Therapeutics's valuation, stock price, and market status.
Is Mirodia Therapeutics a public or private company?
Mirodia Therapeutics is a private company.
What is the current stock price of Mirodia Therapeutics?
Mirodia Therapeutics is a private company, so its shares have no public market price. Caplight tracks Mirodia Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mirodia Therapeutics worth (valuation)?
Valuation information for Mirodia Therapeutics is not publicly available.
Can I buy Mirodia Therapeutics stock?
Mirodia Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mirodia Therapeutics's last funding round?
Mirodia Therapeutics's most recent funding round was Seed on November 1, 2019.
Who are the main investors in Mirodia Therapeutics?
Key investors in Mirodia Therapeutics include Remiges Ventures, ANRI株式会社, Taiho Innovations, LLC.
Will Mirodia Therapeutics IPO soon?
No public IPO plans have been announced for Mirodia Therapeutics.
How can I track Mirodia Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Mirodia Therapeutics's shares on secondary markets.